| Document |
Document Title |
|
WO/2015/118979A1 |
Provided is a thickening agent composition in which a synthetic thickening material, a natural thickening material or a derivative thereof, which has been widely used previously, is contained as the main thickening component and a specif...
|
|
WO/2015/117624A1 |
Method for the production of dextran comprising the following steps: prepare a culture medium containing the appropriated mixture and balance of ingredients, mainly after accurate selection of nature and concentration of carbon and nitro...
|
|
WO/2015/119181A1 |
The purpose is to provide a novel material that enhances the utility of ferrocyanide. The utility of ferrocyanide can be significantly improved by complexing ferrocyanide particles with polysaccharides.
|
|
WO/2015/115609A1 |
Provided are the following: a diamine crosslinking agent for an acidic polysaccharide, the crosslinking agent comprising a diamine compound which has primary amino groups at both terminals and intramolecular ester or thioester bonds and ...
|
|
WO/2015/112907A1 |
This disclosure relates generally to spherical forms comprising cross-linked hyaluronic acid, methods of making such spherical forms and using thereof, for example, in aesthetic applications (e.g., facial contouring, soft tissue augmenta...
|
|
WO/2015/109064A1 |
The present invention is directed toward a process for making a solution of cross-linked poly alpha-1,3-glucan suitable for making a poly alpha-1,3-glucan film. These films can be translucent or transparent and used in packaging applicat...
|
|
WO/2015/109164A1 |
The present invention is directed toward a process for making a gelled network of poly alpha-1,3-glucan formate by addition of water and films made thereof. These films can be translucent or transparent and used in packaging applications.
|
|
WO/2015/109066A1 |
The present invention is directed toward a process for making poly alpha-1,3-glucan formate films. These films are translucent or transparent and can be used in packaging applications.
|
|
WO/2015/103988A1 |
A medical dressing hydrogel composite fabric, and a preparation method therefor and uses thereof. The preparation method comprises: dissolving N-isopropylacrylamide and an initiator by using a solvent, and foaming by using nitrogen; perf...
|
|
WO/2015/103531A1 |
The present invention is directed toward a process for making a poly alpha-1,3-glucan film. These films can be transparent or translucent and used in packaging applications.
|
|
WO/2015/098546A1 |
[Problem] To provide a retarder film that can reduce screen artifacts in high-temperature, high-humidity environments. [Solution] A vertical-alignment retarder film containing a cellulose acetate having a total acyl-group substitution de...
|
|
WO/2015/094402A1 |
Poly alpha-1,3-glucan ester compounds are disclosed herein with a degree of substitution of about 0.05 to about 3.0. Also disclosed are methods of producing poly alpha-1,3-glucan ester compounds and films made therefrom.
|
|
WO/2015/092520A1 |
The present disclosure relates to chitin derivatives of Formula (I), its isomers, prodrugs and pharmaceutically acceptable salts thereof. The present disclosure further relates to a process of preparing the chitin derivatives, its isomer...
|
|
WO/2015/095358A1 |
Poly alpha-1,3-glucan ether compounds are disclosed herein comprising positively charged organic groups. The degree of substitution of the ether compounds is about 0.05 to about 3.0. Also disclosed are methods of producing poly alpha-1,3...
|
|
WO/2015/091160A1 |
The present invention relates to a modified polysaccharide obtainable by a process comprising the step of treating a polysaccharide with gaseous or liquid SO2, a laundry detergent composition comprising said modified polysaccharide, the ...
|
|
WO/2015/095046A1 |
A hydrocolloid or aqueous solution comprising a poly alpha-1,3-glucan ether compound is disclosed having a viscosity of at least about 10 centipoise (cPs). The poly alpha-1,3-glucan ether compound in these compositions has a degree of su...
|
|
WO/2015/086035A1 |
The invention relates to a wood material product or natural-fiber composite material product composed of at least one material containing lignocellulose and/or cellulose, which material has been provided with a formaldehyde-free amino or...
|
|
WO/2015/081966A1 |
A method has been shown for making a co-processed product consisting of at least two components, of which a first component comprises a granular starch, and a second component comprises a non-granular hydrocolloid, a protein, an oil or a...
|
|
WO/2015/085151A1 |
A method of determining the viability of a gum for use in making a product has been achieved by (a) mixing a sample of the gum in a solvent comprising one or more hydroxy moiety containing solvent compound to form a solution with the gum...
|
|
WO/2015/078594A1 |
The invention provides a coffee pulp treatment process comprising (a1) Providing coffee pulp, obtainable from a production process for producing green coffee beans from coffee cherries; (a2) subjecting the coffee pulp to a preservation p...
|
|
WO/2015/079244A1 |
A complex comprising a non-absorbable portion attached to an iron chelator moiety, a composition comprising the complex and the use of the complex in the treatment of colorectal cancer. In one embodiment the non-absorbable portion is a p...
|
|
WO/2015/074632A1 |
The invention relates to nanofibers containing photocurable ester derivatives of hyaluronic acid or its salt, the method of preparation thereof, and the photocured preparation made from the nanofibers by light irradiation and the use the...
|
|
WO/2015/073075A1 |
The present invention provides alkyl substituted polysaccharide compositions and methods of repairing substrates involving use of the alkyl substituted polysaccharide compositions.
|
|
WO/2015/070346A1 |
A process for producing chitin nanocrystals (ChNCs) involves contacting a chitinous material with a sufficient amount of an inorganic persulfate to produce chitin nanocrystals from the chitinous material. The process permits one-spot pro...
|
|
WO/2015/069828A1 |
Solutions formed by combining poly(α(1→3) glucan) with concentrated aqueous formic acid solution, optionally containing methylene chloride, have been shown to produce the formylated form of the poly(α(1→3) glucan). The solutions so...
|
|
WO/2015/064512A1 |
Provided is a polymer compound that is available from a plant as a raw material, can be easily extracted from the raw material, is highly safe, loads a small burden on the environment, and exhibits an excellent thickening effect, where t...
|
|
WO/2015/066171A1 |
Disclosed are methods of treating setts comprising (a) applying a coating of an alginate optionally containing one or more crop protection agents and/or one or more nutrients, and (b) crosslinking the alginate with a divalent metal ion. ...
|
|
WO/2015/056789A1 |
The objective of the present invention is to provide a fiber allowing shape processing using a direct and simple lithographic method, and enabling forming of complex fine fiber patterns. A fiber including: (A) a polymer compound containi...
|
|
WO/2015/054208A1 |
In one aspect, the invention provides injectable compositions that comprise a suitable hydrophilic polymer (e.g., a suitable polysaccharide) and water, as well as other optional components. In various embodiments, the composition may be ...
|
|
WO/2015/048988A1 |
The present invention provides for a method for preparing a thermosensitive hyaluronic acid conjugate comprising the steps of contacting, in any order, a. a predefined amount of hyaluronic acid, b. a predefined amount of one or more ther...
|
|
WO/2015/042711A1 |
Provided herein is chitosan-derivative nanoparticle comprising chitosan functionalized with a cationic amino acid and a hydrophilic polyol; and methods of making and using same, e.g., for gene delivery in vivo.
|
|
WO/2015/036343A1 |
The invention relates to a method for coating a vascular endoprosthesis, wherein the outside of the vascular endoprosthesis is wetted at least partially with a first solution of an active substance, the vascular endoprosthesis is moved i...
|
|
WO/2015/033084A1 |
The present invention relates to a sizing composition for insulating products based on mineral wool, in particular glass or rock wool, which comprises - at least one reducing saccharide, - at least one hydrogenated saccharide, - at least...
|
|
WO/2015/032984A1 |
The application relates to a process for preparing a lypohilized formulation, comprising the steps of: (i) providing (1) a chitosan hydrogel, the chitosan hydrogel being obtainable by providing a chitosan having a degree of deacetylation...
|
|
WO/2015/032314A1 |
The present invention provides a cross-linking agent of an amine compound and the application thereof in a hydrogel preparation method. The cross-linking agent of an amine compound comprises an amine compound, or is prepared by compoundi...
|
|
WO/2015/020024A1 |
[Problem] The present invention addresses the problem of providing a water-soluble pea polysaccharide composition with which moisture absorption during powder storage and the resulting discoloration and caking are controlled and aqueous ...
|
|
WO/2015/018114A1 |
Disclosed is an aqueous composite binder of natural polymer derivative-conducting polymer. The composite binder comprises a natural polymer derivative and a water-soluble conducting polymer at a mass ratio of 1:3.75 to 1:0.038. The compo...
|
|
WO/2015/013821A1 |
The present application is related to a method which allows direct formation of gel-like solutions of polyglucosamine at neutral pH 7 to 8, eliminiating the need of prior dissolution of polyglucosamine in acidic environment, and to a hom...
|
|
WO/2015/008741A1 |
A polarizing plate (3) in which the total thickness of a first protective film (11) and a polarizing film (12) is 50 μm or less. A second protective film (13) contains a cellulose ester and a retardation-lowering agent. The retardation-...
|
|
WO/2015/008743A1 |
A polarizing plate (3) in which the total thickness of a first protective film (11), a polarizing film (12), and a second protective film (13) is 90 μm or less. The moisture permeability of the first protective film (11) is equal to or ...
|
|
WO/2015/004324A1 |
The present invention concerns production of water soluble xylan films in a large scale, where a mixture of xylan, glycerin and water is prepared by dissolving xylan in water, glycerin is added, and the mixture is cast on a moving web, t...
|
|
WO/2015/000055A1 |
A composite includes particles of thermoplastic polymer coated with a chitin nanowhisker gel and melt-blended. The thermoplastic polymer may be polystyrene, polyethylene, acrylonitrile butadiene styrene, polycarbonate, or another thermop...
|
|
WO/2015/002091A1 |
[Problem] To provide a water-soluble hyaluronic acid gel which does not contain a large amount of an organic solvent, and wherein hyaluronic acid is not chemically modified. [Solution] A water-soluble hyaluronic acid gel which contains h...
|
|
WO/2014/201482A1 |
The invention relates to a method for producing polysaccharide fibres containing α(1→3) glucan as the fibre-forming substance, and to the fibres thus produced and the use thereof.
|
|
WO/2014/201484A1 |
The invention relates to a method for producing highly absorbent polysaccharide fibers containing a mixture of cellulose and α(1→3) glucan as a fiber-forming substance. The invention also relates to highly absorbent fibers produced th...
|
|
WO/2014/201483A1 |
The invention relates to a method for producing polysaccharide fibres containing a mixture of cellulose and α(1→3) glucan as a fibre-forming substance. The invention also relates to fibres produced therefrom and to the use of said fib...
|
|
WO/2014/199022A1 |
The invention relates to a method for cross-linking a hyaluronic acid or a salt thereof and optionally other biocompatible polymers, to a method for preparing an injectable hydrogel obtained as per said cross-linking method, to a hydroge...
|
|
WO/2014/198406A1 |
The present invention relates to a method for crosslinking hyaluronic ancid, a method for preparing an injectable hydrogel, the hydrogel thus obtained and its use.
|
|
WO/2014/193816A1 |
The disclosure provides LMWH preparations and methods of analyzing LMWH preparations having at least one chain having a glycol split uronic acid residue (UG) in the preparation for structural signatures, and methods of producing such pre...
|
|
WO/2014/193818A1 |
Described herein are pharmaceutical compositions comprising a LMWH preparation having at least one chain having a glycol split uronic acid residue (UG) in the preparation and uses thereof.
|
